ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 115 filers reported holding ANACOR PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,255,000 | -43.2% | 63,050 | +24.4% | 0.01% | -57.1% |
| Q4 2015 | $5,728,000 | -3.5% | 50,700 | +0.6% | 0.01% | -6.7% |
| Q3 2015 | $5,933,000 | +75.7% | 50,400 | +15.6% | 0.02% | +66.7% |
| Q2 2015 | $3,376,000 | +36.3% | 43,600 | +1.9% | 0.01% | +28.6% |
| Q1 2015 | $2,476,000 | +104.8% | 42,800 | +14.1% | 0.01% | +40.0% |
| Q4 2014 | $1,209,000 | +39.1% | 37,500 | +5.6% | 0.01% | +66.7% |
| Q3 2014 | $869,000 | +38.2% | 35,500 | 0.0% | 0.00% | +50.0% |
| Q2 2014 | $629,000 | – | 35,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |